JPH09154922A - Sterilization washing method for contact lens - Google Patents
Sterilization washing method for contact lensInfo
- Publication number
- JPH09154922A JPH09154922A JP7315398A JP31539895A JPH09154922A JP H09154922 A JPH09154922 A JP H09154922A JP 7315398 A JP7315398 A JP 7315398A JP 31539895 A JP31539895 A JP 31539895A JP H09154922 A JPH09154922 A JP H09154922A
- Authority
- JP
- Japan
- Prior art keywords
- contact lens
- treatment
- cleaning
- acid
- disinfecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 57
- 238000004659 sterilization and disinfection Methods 0.000 title description 26
- 230000001954 sterilising effect Effects 0.000 title description 7
- 238000005406 washing Methods 0.000 title description 5
- 239000002253 acid Substances 0.000 claims abstract description 41
- 239000007788 liquid Substances 0.000 claims description 56
- 238000004140 cleaning Methods 0.000 claims description 48
- 230000000249 desinfective effect Effects 0.000 claims description 38
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 abstract description 29
- 150000004820 halides Chemical class 0.000 abstract description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 6
- 239000011780 sodium chloride Substances 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 21
- 230000000694 effects Effects 0.000 description 15
- -1 chlorohexidine Chemical class 0.000 description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 108091005804 Peptidases Proteins 0.000 description 9
- 102000035195 Peptidases Human genes 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 8
- 239000000607 artificial tear Substances 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 239000006172 buffering agent Substances 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 5
- 239000003638 chemical reducing agent Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003792 electrolyte Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 239000012670 alkaline solution Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 241000228212 Aspergillus Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000008151 electrolyte solution Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 229940023064 escherichia coli Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- JGJLWPGRMCADHB-UHFFFAOYSA-N hypobromite Chemical compound Br[O-] JGJLWPGRMCADHB-UHFFFAOYSA-N 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 108090001069 Chymopapain Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000078604 Diplophyllum albicans Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229960002976 chymopapain Drugs 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000003411 electrode reaction Methods 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 231100000040 eye damage Toxicity 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- AAUNBWYUJICUKP-UHFFFAOYSA-N hypoiodite Chemical compound I[O-] AAUNBWYUJICUKP-UHFFFAOYSA-N 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- SRPSOCQMBCNWFR-UHFFFAOYSA-N iodous acid Chemical compound OI=O SRPSOCQMBCNWFR-UHFFFAOYSA-N 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- SATVIFGJTRRDQU-UHFFFAOYSA-N potassium hypochlorite Chemical compound [K+].Cl[O-] SATVIFGJTRRDQU-UHFFFAOYSA-N 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- ORQYPOUSZINNCB-UHFFFAOYSA-N potassium;hypobromite Chemical compound [K+].Br[O-] ORQYPOUSZINNCB-UHFFFAOYSA-N 0.000 description 1
- UJQKSBYNVKHMFX-UHFFFAOYSA-N potassium;hypoiodite Chemical compound [K+].I[O-] UJQKSBYNVKHMFX-UHFFFAOYSA-N 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229940098362 serratia marcescens Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- CRWJEUDFKNYSBX-UHFFFAOYSA-N sodium;hypobromite Chemical compound [Na+].Br[O-] CRWJEUDFKNYSBX-UHFFFAOYSA-N 0.000 description 1
- SAFWHKYSCUAGHQ-UHFFFAOYSA-N sodium;hypoiodite Chemical compound [Na+].I[O-] SAFWHKYSCUAGHQ-UHFFFAOYSA-N 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
Landscapes
- Eyeglasses (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、コンタクトレンズ
の消毒洗浄方法に関する。さらに詳しくは、次亜ハロゲ
ン酸のすぐれた消毒洗浄効果を利用するとともに、次亜
ハロゲン酸をすみやかに無毒化することができ、構造が
簡単な処理装置に好適に使用しうるコンタクトレンズの
消毒洗浄方法に関する。TECHNICAL FIELD The present invention relates to a method for disinfecting and cleaning contact lenses. More specifically, while utilizing the excellent disinfecting and cleaning effect of hypohalous acid, it is possible to quickly detoxify hypohalous acid, and disinfecting and cleaning contact lenses that can be suitably used in a treatment device with a simple structure. Regarding the method.
【0002】[0002]
【従来の技術】コンタクトレンズには、その装用に伴な
って環境中の汚れ、微生物、涙液中の蛋白質などが付着
するので、そのままでは長期間装用しつづけると目を害
する危惧がある。したがって、これを定期的に、好まし
くは毎日洗浄したり、消毒する必要がある。2. Description of the Related Art Contact lenses, when worn, are contaminated with dirt, microorganisms, proteins in tears, etc. in the environment, and therefore, if they are worn as they are for a long time, they may damage the eyes. It therefore needs to be cleaned and disinfected regularly, preferably daily.
【0003】前記コンタクトレンズの消毒洗浄方法とし
ては、従来、界面活性剤入りソリューションを用いて手
指により洗浄する方法が知られているが、かかる消毒洗
浄方法では、表面の汚れを取り除くことは可能である
が、たとえばハード系コンタクトレンズに適用したばあ
いには、洗浄中に破損したり、傷が入るおそれがあり、
また含水性ソフトコンタクトレンズに適用したばあいに
は、コンタクトレンズの内部に入り込んでいる蛋白質な
どの汚れを完全に除去することができない。As a method of disinfecting and cleaning the contact lens, a method of cleaning with a finger using a solution containing a surfactant is conventionally known. However, such a disinfecting and cleaning method cannot remove dirt on the surface. However, when applied to hard contact lenses, for example, they may be damaged or scratched during cleaning,
Further, when applied to a hydrous soft contact lens, it is not possible to completely remove stains such as proteins that have entered the inside of the contact lens.
【0004】また、蛋白質に汚染されたコンタクトレン
ズを再生利用するための洗浄方法としては、蛋白質分解
酵素を含む洗浄剤を用いる方法が知られている。しかし
ながら、かかる方法を用いたばあいには、コンタクトレ
ンズの表面に付着した蛋白質を分解させることができる
が、酵素が用いられるため長時間を要する。とくに、か
かる洗浄剤を用いて含水性ソフトコンタクトレンズを洗
浄したばあいには、レンズ内部で変性した蛋白質を分解
させるためには、蛋白質分解酵素自体もレンズ内部に侵
入させなければならないので、ハード系コンタクトレン
ズよりもさらに長時間の処理が必要であるばかりか、充
分な蛋白質除去効果を期待することができない。As a cleaning method for reusing a contact lens contaminated with protein, a method using a cleaning agent containing a proteolytic enzyme is known. However, when such a method is used, the protein attached to the surface of the contact lens can be decomposed, but it takes a long time because an enzyme is used. In particular, when a water-containing soft contact lens is washed with such a detergent, in order to decompose the denatured protein inside the lens, the proteolytic enzyme itself must also enter the inside of the lens. In addition to the need for treatment for a longer period of time than that of the system contact lens, a sufficient protein removing effect cannot be expected.
【0005】また、米国特許第4,732,185号明
細書には、pH8〜9のホウ酸−EDTA緩衝液に一定
方向の電場を形成させてコンタクトレンズを浸漬して電
気泳動によって蛋白質を除去し、洗浄する方法が記載さ
れている。この方法で洗浄を行なえば、確かに含水性コ
ンタクトレンズ内部に侵入している蛋白質を除去するこ
とができるが、かかる方法を行なう前提として、蛋白質
が変性しておらず、しかもイオン化された状態であるこ
とが必要であり、また処理に要する時間が長時間である
などの問題点がある。Further, in US Pat. No. 4,732,185, a boric acid-EDTA buffer solution having a pH of 8 to 9 is used to form an electric field in a certain direction to immerse a contact lens, and proteins are removed by electrophoresis. The method of cleaning and washing is described. If washing is performed by this method, it is possible to remove the protein invading the inside of the hydrous contact lens, but the precondition for carrying out such a method is that the protein is not denatured and is ionized. However, there is a problem in that it is necessary and that the processing time is long.
【0006】一方、含水性ソフトコンタクトレンズの消
毒方法としては、コンタクトレンズを過酸化水素水に浸
漬して消毒し、金属触媒、還元剤および酵素触媒を用い
て過酸化水素を分解し、無毒化する方法や、クロロヘキ
シジンなどの化合物を利用した消毒方法などが知られて
いる。On the other hand, as a method for disinfecting a hydrous soft contact lens, the contact lens is immersed in hydrogen peroxide solution to disinfect it, and hydrogen peroxide is decomposed using a metal catalyst, a reducing agent and an enzyme catalyst to detoxify it. There are known methods for disinfection, disinfection methods using compounds such as chlorohexidine, and the like.
【0007】しかしながら、過酸化水素水を使用する方
法は、含水性ソフトコンタクトレンズ中に残存する過酸
化水素を分解しなければならないため、その操作に長時
間を要するうえに、コンタクトレンズ内部に残存する過
酸化水素が完全に分解されていないと装用時に目にしみ
るなどの刺激が付与されるため、適当な消毒方法である
とはいえない。また、クロロヘキシジンなどの化合物を
使用した消毒方法では、その化合物がレンズに吸着した
り、残存した化合物によって目などに対してアレルギー
性の反応が引き起こされる危険性がある。However, in the method using hydrogen peroxide solution, the hydrogen peroxide remaining in the hydrous soft contact lens must be decomposed, so that the operation takes a long time and the hydrogen peroxide remains inside the contact lens. If the hydrogen peroxide is not completely decomposed, it causes irritation such as eye contact during wearing, so it cannot be said to be an appropriate disinfection method. Further, in the disinfection method using a compound such as chlorohexidine, there is a risk that the compound may be adsorbed on the lens, or the remaining compound may cause an allergic reaction to eyes and the like.
【0008】一方、次亜塩素酸を使用する消毒方法によ
れば、数ppmの濃度で黄色ブドウ球菌(Staphy
lococcus aureus)、大腸菌(Esch
erichia coli)、緑膿菌(Pseudom
onas aeruginosa)、カンジダ(Can
dida albicans)などの目の病原体を短時
間で消毒することができ、またレンズに付着した蛋白質
などの有機物の汚れを除去させることができる。On the other hand, according to the disinfection method using hypochlorous acid, Staphylococcus aureus ( Staphy) at a concentration of several ppm
lococcus aureus ), E. coli ( Esch
erichia coli ), Pseudomonas aeruginosa ( Pseudom )
onas aeruginosa ), Candida ( Can
It is possible to disinfect an eye pathogen such as D. albicans ) in a short time, and to remove stains of organic substances such as proteins attached to the lens.
【0009】かかる次亜塩素酸を用いた方法としては、
特開昭56−68454号公報に記載の電気分解によっ
て次亜塩素酸を生成させて消毒する方法があるが、該方
法は、処理後に残存する次亜塩素酸が自然消失するまで
に時間がかかり、長時間コンタクトレンズを次亜塩素酸
溶液中に浸漬するので、コンタクトレンズのカラーが脱
色されたり、マークが脱離してしまうという問題があ
る。As a method using such hypochlorous acid,
There is a method of producing hypochlorous acid by electrolysis as described in JP-A-56-68454 to disinfect it. However, this method takes time until the hypochlorous acid remaining after treatment spontaneously disappears. Since the contact lens is immersed in the hypochlorous acid solution for a long time, there is a problem that the color of the contact lens is discolored or the mark is detached.
【0010】また、次亜塩素酸を用いて消毒処理を施し
たレンズは、そのままの状態で目に装用することができ
ないので、適当な金属触媒や還元剤を用いて消毒処理後
に残存する次亜塩素酸を不活性化させる方法が提案され
ている。かかる方法としては、たとえば特開平5−19
218号公報に記載の次亜塩素酸を金属触媒によって還
元無毒化する方法、特開昭50−106492号公報お
よび特開平4−190214号公報に記載の次亜塩素酸
を還元剤によって還元無毒化する方法などがある。Further, a lens which has been disinfected with hypochlorous acid cannot be worn as it is on the eye, and therefore, a hypochlorite remaining after disinfection using an appropriate metal catalyst or reducing agent. Methods have been proposed for deactivating chloric acid. As such a method, for example, Japanese Patent Laid-Open No. 5-19
No. 218, a method of reducing and detoxifying hypochlorous acid with a metal catalyst, and a method of reducing and detoxifying hypochlorous acid with a reducing agent described in JP-A Nos. 50-106492 and 4-190214. There are ways to do it.
【0011】しかしながら、消毒処理後にこのような還
元操作を行なうことは、レンズの無菌性が保ちがたくな
ることや、還元操作自体が煩雑であり、還元操作が終わ
るまでにレンズが長時間、高濃度の次亜塩素酸イオンの
作用を受けることにより、レンズの材質劣化やカラーの
褪色が発生するなどの問題があり、また、還元操作が正
しく実施されなかったばあいには、レンズ装用時に眼組
織に対して害を与えるという問題があった。However, performing such a reducing operation after the disinfection treatment makes it difficult to maintain the sterility of the lens, and the reducing operation itself is complicated, so that the lens is kept for a long time and high before the reducing operation is completed. There is a problem such as deterioration of the material of the lens and discoloration of the color due to the action of hypochlorite ion at a high concentration, and if the reduction operation is not performed correctly, it may cause eye damage when wearing the lens. There was a problem of harming the organization.
【0012】さらに、特開昭63−254416号公報
および特開昭63−254417号公報には、洗浄層中
の電解液をイオン交換膜を貼った隔壁で2分し、該電解
液に直流電流を流すことによって次亜塩素酸を含む酸性
液とアルカリ液とを生成させ、コンタクトレンズをアル
カリ液で洗浄し、ついで逆方向に電流を流すことでコン
タクトレンズが浸漬されたアルカリ液を中和させる方法
が提案されているが、これらの方法では、液性(pH)
は中和されるが、発生した次亜塩素酸が還元されること
なく溶液内に残存するため、処理後にそのままレンズを
装用することができないという問題がある。Further, in JP-A-63-254416 and JP-A-63-254417, the electrolytic solution in the cleaning layer is divided into two parts by a partition having an ion exchange membrane, and a direct current is applied to the electrolytic solution. To generate an acidic solution containing hypochlorous acid and an alkaline solution, wash the contact lens with the alkaline solution, and then apply an electric current in the opposite direction to neutralize the alkaline solution in which the contact lens is immersed. Although methods have been proposed, in these methods, liquid (pH)
However, since the generated hypochlorous acid remains in the solution without being reduced, there is a problem that the lens cannot be worn as it is after the treatment.
【0013】そこで、本発明者らは、これら従来の問題
点を解決しうるコンタクトレンズの洗浄殺菌方法とし
て、次亜ハロゲン酸またはハロゲン化物を含有する処理
液にコンタクトレンズを浸漬し、該処理液に電極の正極
と負極を複数回繰り返して逆転させて直流電流を通電す
る方法を提案しており(特開平7−104221号公
報)、かかる方法によれば、次亜ハロゲン酸によってコ
ンタクトレンズが洗浄殺菌されるとともに、かかる次亜
ハロゲン酸は、すみやかに無毒化されることが明らかと
なっている。Therefore, as a method of cleaning and sterilizing a contact lens capable of solving these conventional problems, the inventors of the present invention immerse the contact lens in a treatment liquid containing hypohalous acid or a halide, and Japanese Patent Application Laid-Open No. 7-104221 proposes a method in which a positive electrode and a negative electrode of an electrode are repeatedly inverted for a plurality of times to apply a direct current (Japanese Patent Application Laid-Open No. 7-104221). It has been clarified that such hypohalous acid is promptly detoxified with sterilization.
【0014】[0014]
【発明が解決しようとする課題】本発明は、前記方法の
さらなる向上を試みてなされたものであり、次亜ハロゲ
ン酸のすぐれた消毒力および洗浄力によってコンタクト
レンズを消毒洗浄させるとともに、かかる次亜ハロゲン
酸をよりすみやかに無毒化させうるコンタクトレンズの
消毒洗浄方法を提供することを目的とするものである。DISCLOSURE OF THE INVENTION The present invention has been made in an attempt to further improve the above-mentioned method, and disinfects and cleans contact lenses by the excellent disinfecting power and cleaning power of hypohalous acid. It is an object of the present invention to provide a method for disinfecting and cleaning contact lenses, which can detoxify halogenous acid more quickly.
【0015】本発明は、さらには電力をできるだけ小さ
くすることによって感電や漏電に対する電気的安全性が
高められ、電池やバッテリーなどの使用によって携帯に
便利であり、構造が簡単なコンタクトレンズ処理装置に
好適に使用することができ、かかる処理装置の電極の耐
用日数をより長くし、さらに低コスト化を図ることがで
きるコンタクトレンズの電気的処理方法を提供すること
を目的とするものである。The present invention further improves the electrical safety against electric shock and leakage by reducing the electric power as much as possible, and makes it possible to provide a contact lens processing device which is convenient to carry by using a battery or battery and has a simple structure. It is an object of the present invention to provide an electrical treatment method for a contact lens, which can be preferably used, can prolong the service life of the electrode of such a treatment device, and can further reduce the cost.
【0016】[0016]
【課題を解決するための手段】本発明は、ハロゲン化物
を含有しないが、次亜ハロゲン酸を含有する処理液中に
コンタクトレンズを浸漬したのち、前記処理液に直流電
流を通電することを特徴とするコンタクトレンズの消毒
洗浄方法に関する。The present invention is characterized in that a contact lens is not contained in a halide but is immersed in a treatment solution containing hypohalous acid, and then a direct current is applied to the treatment solution. And a method for disinfecting and cleaning contact lenses.
【0017】[0017]
【発明の実施の形態】本発明のコンタクトレンズの消毒
洗浄方法は、前記したように、ハロゲン化物を含有しな
いが、次亜ハロゲン酸を含有する処理液中にコンタクト
レンズを浸漬したのち、前記処理液に直流電流を通電す
ることを特徴とするものである。BEST MODE FOR CARRYING OUT THE INVENTION As described above, the method of disinfecting and cleaning a contact lens according to the present invention comprises the steps of immersing a contact lens in a treatment solution containing a hypohalous acid, which does not contain a halide. It is characterized in that a direct current is passed through the liquid.
【0018】なお、本発明で次亜ハロゲン酸とは、酸化
数+1のハロゲンを含む酸素酸で、一般式:HXO(式
中、XはCl、BrまたはIを示す)で表わされるもの
をいい、次亜ハロゲン酸イオン(XO- )を含むもので
ある。In the present invention, the hypohalous acid is an oxygen acid containing halogen of oxidation number +1 and is represented by the general formula: HXO (wherein X represents Cl, Br or I). , Hypohalous acid ion (XO − ).
【0019】本発明は、次亜ハロゲン酸の消毒洗浄効果
を利用したのち、次亜ハロゲン酸をすみやかに無毒化し
うるものである。The present invention is capable of promptly detoxifying hypohalous acid after utilizing the disinfecting and cleaning effect of hypohalous acid.
【0020】本発明の消毒洗浄方法に用いられる処理液
は、ハロゲン化物を含有しないが、次亜ハロゲン酸を含
有するものであり、かかる次亜ハロゲン酸としては、次
亜塩素酸、次亜臭素酸および次亜ヨウ素酸があげられ
る。また、前記ハロゲン化物とは、たとえば塩化ナトリ
ウム、塩化カリウムなどの塩化物;臭化ナトリウム、臭
化カリウムなどの臭化物;ヨウ化ナトリウム、ヨウ化カ
リウムなどのヨウ化物などである。The treatment liquid used in the disinfecting and cleaning method of the present invention does not contain a halide, but contains hypohalous acid. Examples of such hypohalous acid include hypochlorous acid and hypobromite. Acids and hypoiodic acid are mentioned. Examples of the halides include chlorides such as sodium chloride and potassium chloride; bromides such as sodium bromide and potassium bromide; iodides such as sodium iodide and potassium iodide.
【0021】前記処理液中の次亜ハロゲン酸の濃度は、
コンタクトレンズに損傷を与えるおそれが生じないよう
にするためには、200ppm以下、好ましくは100
ppm以下であることが望ましく、また充分な消毒洗浄
効果を発現させるためには、0.1ppm以上、好まし
くは1ppm以上であることが望ましい。なお、前記次
亜ハロゲン酸の濃度は、コンタクトレンズの消毒処理の
みを行なうばあいには、2〜10ppm程度であること
が好ましく、また消毒処理および蛋白質などの有機物の
汚れの洗浄処理を行なうばあいには、20ppm以上で
あることが好ましい。The concentration of hypohalous acid in the treatment liquid is
In order to prevent the possibility of damaging the contact lens, the amount is 200 ppm or less, preferably 100 ppm or less.
It is desirable that the content be ppm or less, and in order to exhibit a sufficient disinfecting and cleaning effect, it should be 0.1 ppm or more, preferably 1 ppm or more. The concentration of the hypohalous acid is preferably about 2 to 10 ppm when only disinfecting the contact lens, and when disinfecting and cleaning the organic dirt such as protein. However, it is preferably 20 ppm or more.
【0022】前記次亜ハロゲン酸を含有する処理液をう
る方法としては、たとえば次亜塩素酸ナトリウム、次亜
塩素酸カリウムなどの次亜塩素酸塩;次亜臭素酸ナトリ
ウム、次亜臭素酸カリウムなどの次亜臭素酸塩;次亜ヨ
ウ素酸ナトリウム、次亜ヨウ素酸カリウムなどの次亜ヨ
ウ素酸塩などの次亜ハロゲン酸塩を水などに添加する方
法などがあげられる。なお、本発明において前記方法を
用いるばあい、通常、次亜ハロゲン酸を含有する処理液
を調製したのち、該処理液にコンタクトレンズを浸漬す
るが、あらかじめコンタクトレンズが浸漬された水など
に次亜ハロゲン酸塩を添加してもよい。As a method for obtaining a treatment solution containing the hypohalous acid, for example, hypochlorites such as sodium hypochlorite and potassium hypochlorite; sodium hypobromite and potassium hypobromite. And the like, and a method of adding hypohalite such as hypoiodite such as sodium hypoiodite and potassium hypoiodite to water and the like. When the above method is used in the present invention, usually, after preparing a treatment liquid containing hypohalous acid, the contact lens is immersed in the treatment liquid. Halogite may be added.
【0023】本発明において、前記処理液中にコンタク
トレンズを浸漬したのち、該処理液に直流電流を通電す
ることによって消毒洗浄処理が行なわれるが、かかる処
理に要する時間は、処理液中の次亜ハロゲン酸の濃度、
電流値などによって多少異なるが、通常1〜200分間
程度、なかんづく5〜150分間程度であることが好ま
しい。In the present invention, after immersing the contact lens in the treatment liquid, a disinfecting and cleaning treatment is carried out by applying a direct current to the treatment liquid. The time required for such treatment is as follows. Concentration of halous acid,
Although it varies somewhat depending on the current value and the like, it is usually about 1 to 200 minutes, preferably about 5 to 150 minutes.
【0024】本発明において、コンタクトレンズを浸漬
した処理液に直流電流を通電するばあいの電極の材料と
しては、溶出などの劣化をおこしにくいイオン化傾向が
小さい材料が好ましい。かかる電極の材料の代表例とし
ては、たとえば金、白金などの貴金属、これら貴金属で
メッキ処理または蒸着処理が施された合成樹脂やセラミ
ックなどがあげられる。In the present invention, when a direct current is applied to the treatment solution in which the contact lens is immersed, a material having a small ionization tendency that is resistant to deterioration such as elution is preferable as a material for the electrode. Typical examples of the material for such electrodes include noble metals such as gold and platinum, and synthetic resins and ceramics plated or vapor-deposited with these noble metals.
【0025】処理液に通電させる直流電流の電流値は、
処理液の種類や電極面積に応じて適宜選択すればよい
が、次亜ハロゲン酸の還元をよりすみやかにするために
は、0.001A以上、好ましくは0.01A以上であ
ることが望ましく、また処理液の液温が上昇し、たとえ
ばハード系コンタクトレンズや高含水ソフトコンタクト
レンズなどの消毒洗浄を行なったときに、ハード系コン
タクトレンズの変形、高含水ソフトコンタクトレンズの
材質の劣化などの熱的な劣化を引き起こす原因となった
り、また所望の電流値をうるために高電圧を必要とし、
感電、漏電などの電気的な安全性が低下するおそれをな
くするためには、0.5A以下、好ましくは0.2A以
下であることが望ましい。The current value of the direct current supplied to the treatment liquid is
It may be appropriately selected according to the type of treatment liquid and the electrode area, but in order to accelerate the reduction of hypohalous acid, 0.001 A or more, preferably 0.01 A or more is desirable, and When the temperature of the treatment liquid rises and, for example, when disinfecting and cleaning hard contact lenses and high water content soft contact lenses, thermal deformation such as deformation of hard contact lenses and deterioration of the material of high water content soft contact lenses occurs. Cause high quality deterioration, and require high voltage to obtain desired current value,
In order to eliminate the risk of electrical safety such as electric shock and leakage, it is preferably 0.5 A or less, and more preferably 0.2 A or less.
【0026】前記電極間に印加する直流電流の電圧は、
消毒洗浄効果の低下や次亜ハロゲン酸の還元に長時間を
要するなどの問題が生じるおそれをなくすためには、1
V以上、好ましくは1.5V以上、さらに好ましくは2
V以上であることが望ましく、また処理液の液温が必要
以上に上昇し、消毒洗浄を行なったとき、コンタクトレ
ンズが熱的に劣化したり、また感電、漏電などの電気的
な安全性が低下するおそれをなくすためには、40V以
下、好ましくは20V以下、さらに好ましくは10V以
下であることが望ましい。The voltage of the direct current applied between the electrodes is
In order to eliminate the problems such as a decrease in disinfecting and cleaning effect and a long time required for the reduction of hypohalous acid, 1
V or higher, preferably 1.5 V or higher, more preferably 2
It is preferable that the temperature is V or higher, and the temperature of the treatment liquid rises more than necessary, and when disinfecting and cleaning, the contact lens is thermally deteriorated, and electrical safety such as electric shock and leakage is caused. In order to eliminate the risk of reduction, it is desirable that the voltage is 40 V or less, preferably 20 V or less, and more preferably 10 V or less.
【0027】なお、かかる処理液に直流電流を通電する
時間は、溶液中に存在する次亜ハロゲン酸を還元無毒化
するために必要な時間よりも長ければよく、安全性の点
から30秒〜120分間程度であることが好ましい。The time for applying a direct current to the treatment solution may be longer than the time required for reducing and detoxifying the hypohalous acid present in the solution, and from the viewpoint of safety, it is 30 seconds to 30 seconds. It is preferably about 120 minutes.
【0028】本発明に用いられる処理液には、必要に応
じて、たとえば緩衝剤、電解質などを適宜配合すること
ができる。The treatment liquid used in the present invention may optionally contain, for example, a buffering agent and an electrolyte.
【0029】前記緩衝剤は、処理液のpHを安定せしめ
るための成分であり、かかる緩衝剤を用いることによ
り、処理液のpHを生理的に等張な6〜7.5程度に調
整することが好ましい。The buffering agent is a component for stabilizing the pH of the treatment liquid. By using such a buffering agent, the pH of the treatment liquid should be adjusted to a physiologically isotonic level of about 6 to 7.5. Is preferred.
【0030】前記緩衝剤としては、たとえばリン酸塩、
ホウ酸塩などがあげられ、これらは単独でまたは2種以
上を混合して用いることができる。なお、かかる緩衝剤
の処理液中の濃度は、たとえば後述する電解質などと併
用したとき、これらをあわせた濃度が高くなって処理液
の浸透圧が高くなりすぎ、かかる処理液を用いて消毒洗
浄を行なったコンタクトレンズを装用すると、眼が刺激
されるようになるおそれをなくすためには、通常0.2
mol/リットル以下、好ましくは0.0001〜0.
05mol/リットルであることが望ましい。Examples of the buffering agent include phosphate,
Examples thereof include borate, and these can be used alone or in admixture of two or more. The concentration of such a buffering agent in the treatment liquid is, for example, when used in combination with an electrolyte, etc., which will be described later, the combined concentration of the buffering agents becomes high and the osmotic pressure of the treatment liquid becomes too high. Wearing a contact lens that has been subjected to
mol / liter or less, preferably 0.0001-0.
It is preferably 05 mol / liter.
【0031】前記電解質は、処理液の電気伝導度を上昇
させ、浸透圧を調整せしめるための成分である。The electrolyte is a component for increasing the electric conductivity of the processing liquid and adjusting the osmotic pressure.
【0032】前記電解質としては、たとえば硫酸ナトリ
ウム、炭酸ナトリウム、リン酸ナトリウム、硝酸ナトリ
ウム、炭酸カルシウム、硫酸カルシウム、硫酸カリウム
などがあげられ、これらは単独でまたは2種以上を混合
して用いることができる。なお、かかる電解質の濃度
は、たとえば前記緩衝剤などとあわせて、処理液の浸透
圧が250〜350mmol/kgとなるように調整す
ることが好ましい。Examples of the electrolyte include sodium sulfate, sodium carbonate, sodium phosphate, sodium nitrate, calcium carbonate, calcium sulfate, potassium sulfate, etc. These may be used alone or in combination of two or more. it can. The concentration of the electrolyte is preferably adjusted in combination with, for example, the above buffer so that the osmotic pressure of the treatment liquid is 250 to 350 mmol / kg.
【0033】本発明の消毒洗浄方法においては、たとえ
ば前記のようにして次亜ハロゲン酸を含有する処理液を
調製し、該処理液にコンタクトレンズを浸漬したのち、
該処理液に直流電流を通電して処理液中の次亜ハロゲン
酸を還元して無毒化させる。このような本発明の消毒洗
浄方法によれば、消毒や洗浄に充分な濃度の次亜ハロゲ
ン酸を短時間で処理液中から完全に還元して無毒化する
ことができる。In the disinfecting and cleaning method of the present invention, for example, a treatment solution containing hypohalous acid is prepared as described above, and a contact lens is immersed in the treatment solution.
A direct current is applied to the treatment liquid to reduce hypohalous acid in the treatment liquid to detoxify it. According to such a disinfecting and cleaning method of the present invention, hypohalous acid having a sufficient concentration for disinfection and cleaning can be completely reduced from the treatment liquid in a short time to make it nontoxic.
【0034】なお、本発明の消毒洗浄方法においては、
コンタクトレンズに付着している脂質などの汚れを充分
に除去するために、コンタクトレンズを処理液に浸漬す
る前に該処理液中に界面活性剤を含有させるか、または
消毒洗浄したのちに界面活性剤を含有する洗浄液でコン
タクトレンズを洗浄してもよい。In the disinfecting and cleaning method of the present invention,
In order to sufficiently remove stains such as lipids adhering to the contact lens, a surfactant is contained in the treatment solution before the contact lens is immersed in the treatment solution, or after the disinfection and cleaning, the surface activity of the contact lens is reduced. You may wash a contact lens with the washing | cleaning liquid containing an agent.
【0035】前記界面活性剤としては、たとえば高級ア
ルコールおよび液体脂肪油の硫酸エステル、アルキルエ
ーテル硫酸エステル、アルキルスルホネート、スルホコ
ハク酸エステル、アルキルエーテルスルホン酸ナトリウ
ムなどの陰イオン性界面活性剤、アルキルアミン塩、ア
ルキルアンモニウム塩などの陽イオン性界面活性剤、ア
ルキルエーテル、アルキルフェニルエーテル、ポリオキ
シプロピレンエーテル、アルキルエステルグリセリン脂
肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシ
エチレンソルビタン脂肪酸エステルなどの非イオン性界
面活性剤などがあげられ、これらは単独でまたは2種以
上を混合して用いることができる。Examples of the surfactants include anionic surfactants such as sulfuric acid esters of higher alcohols and liquid fatty oils, alkyl ether sulfuric acid esters, alkyl sulfonates, sulfosuccinic acid esters, sodium alkyl ether sulfonates, and alkyl amine salts. , Cationic surfactants such as alkylammonium salts, nonionic surfactants such as alkyl ethers, alkylphenyl ethers, polyoxypropylene ethers, alkyl ester glycerin fatty acid esters, sorbitan fatty acid esters, polyoxyethylene sorbitan fatty acid esters, etc. These may be used alone or in admixture of two or more.
【0036】なお、前記界面活性剤を処理液中に含有さ
せて用いるばあいには、含有された次亜ハロゲン酸と反
応しない界面活性剤を用いればよく、このような界面活
性剤としては、たとえばアルキルエーテルスルホン酸ナ
トリウムなどがあげられる。また、該界面活性剤の濃度
があまりにも高すぎるばあいには、電極反応によって発
生するガスのため、処理液に過剰の気泡が発生して容器
から該処理液があふれることがあるので、該界面活性剤
の処理液中の濃度は、0.1重量%以下、なかんづく
0.05重量%以下であることが好ましい。When the above-mentioned surfactant is used by being contained in the treatment liquid, a surfactant which does not react with the contained hypohalous acid may be used. As such a surfactant, For example, sodium alkyl ether sulfonate and the like can be mentioned. Further, if the concentration of the surfactant is too high, the gas generated by the electrode reaction may cause excessive bubbles in the treatment liquid to overflow the treatment liquid from the container. The concentration of the surfactant in the treatment liquid is preferably 0.1% by weight or less, more preferably 0.05% by weight or less.
【0037】また、コンタクトレンズ内部に変性した蛋
白質などの除去しにくい蛋白質の汚れが存在するばあい
には、前記処理前に蛋白質分解酵素を含有する溶液と接
触させて変性した蛋白質などが除去されやすくしてもよ
い。If stains of denatured proteins and other proteins that are difficult to remove exist inside the contact lens, the denatured proteins and the like are removed by contact with a solution containing a proteolytic enzyme before the treatment. May be easier.
【0038】前記蛋白質分解酵素としては、たとえばパ
パイン、キモパパイン、パンクレアチン、トリプシン、
キモトリプシン、ペプシン、フィシン、カルボキシペプ
チターゼ、アミノペプチターゼ、ブロメリンなどの植物
性蛋白質分解酵素や動物性蛋白質分解酵素、バチルス、
ストレプトミセス細菌やアスペルギウス糸状菌などの微
生物由来の蛋白質分解酵素などがあげられ、これらは単
独でまたは2種以上を混合して用いることができる。な
お、かかる蛋白質分解酵素の処理液中の濃度は、該処理
液中の蛋白質分解酵素活性が300〜1000unit
/mlとなるように調整することが好ましい。Examples of the proteolytic enzyme include papain, chymopapain, pancreatin, trypsin,
Chymotrypsin, pepsin, ficin, carboxypeptidase, aminopeptidase, bromelin and other plant proteinases and animal proteinases, Bacillus,
Examples thereof include proteolytic enzymes derived from microorganisms such as Streptomyces bacteria and Aspergius filamentous fungi, and these can be used alone or in combination of two or more. The concentration of the proteolytic enzyme in the treatment liquid is such that the proteolytic enzyme activity in the treatment liquid is 300 to 1000 unit.
It is preferable to adjust it to be / ml.
【0039】かくして直流電流を通電して消毒洗浄処理
後の次亜ハロゲン酸を還元させて無毒化させることによ
り、消毒洗浄処理が施されたコンタクトレンズを処理液
から取り出してそのまま目に装用することができる。Thus, by applying a direct current to reduce the hypohalous acid after the disinfecting and cleaning treatment to make it non-toxic, the contact lens that has been subjected to the disinfecting and cleaning treatment is taken out from the treatment liquid and put on the eye as it is. You can
【0040】次亜ハロゲン酸によるコンタクトレンズの
消毒洗浄効果は、短時間で現れるので、消毒洗浄処理が
施されたのちは、できるだけすみやかに次亜ハロゲン酸
を還元することがコンタクトレンズに損傷を与えないと
いう点から好ましい。Since the disinfecting and cleaning effect of the contact lens by hypohalous acid appears in a short time, it is necessary to reduce the hypohalous acid as soon as possible after the disinfecting and cleaning treatment to damage the contact lens. It is preferable because it does not exist.
【0041】したがって、たとえば従来の還元剤を用い
た方法では、消毒洗浄処理が終了してから還元剤を作用
させるまでに時間がかかり、また還元触媒を用いた方法
においては、還元に長時間を要するため、還元終了まで
次亜ハロゲン酸の濃度が高いままの状態でコンタクトレ
ンズが必要以上に浸漬され続けており、その損傷が大き
いといった問題があったのに対し、本発明においては、
用いる処理液に応じて、たとえばタイマーなどで時間を
設定して電流を制御しながら通電することにより、消毒
洗浄処理後、きわめて短時間で次亜ハロゲン酸を還元し
て無毒化することができるので、コンタクトレンズに損
傷を与えることがない。Therefore, for example, in the conventional method using a reducing agent, it takes time until the reducing agent acts after the disinfection / cleaning treatment is completed, and in the method using a reducing catalyst, the reduction takes a long time. Therefore, the contact lens continues to be unnecessarily immersed in a state where the concentration of hypohalous acid remains high until the end of reduction, and there is a problem that the damage is large, whereas in the present invention,
Depending on the treatment liquid used, for example, by setting the time with a timer etc. and energizing while controlling the current, it is possible to reduce the hypohalous acid and detoxify it in a very short time after the disinfection and cleaning treatment. , Does not damage contact lenses.
【0042】また、本発明の消毒洗浄方法は、消毒洗浄
処理後に煩雑な操作を必要とせずに、処理液から取り出
したコンタクトレンズをそのまま目に装用することがで
き、コンタクトレンズの無菌性がきわめて良好に保たれ
るので、コンタクトレンズの消毒洗浄方法としてきわめ
て有用なものである。Further, in the disinfecting and cleaning method of the present invention, the contact lens taken out from the processing liquid can be directly worn on the eyes without requiring a complicated operation after the disinfecting and cleaning treatment, and the sterility of the contact lens is extremely high. Since it is maintained well, it is extremely useful as a method for disinfecting and cleaning contact lenses.
【0043】さらに、本発明の消毒洗浄方法は、処理液
に直流電流を通電するだけでよいので、構造が簡単なコ
ンタクトレンズ処理装置に好適に使用することができ、
かかる処理装置の電極の耐用日数をより長くし、さらに
低コスト化を図ることができるといったすぐれた効果も
発現するものである。Further, since the disinfecting and cleaning method of the present invention need only apply a direct current to the processing liquid, it can be suitably used for a contact lens processing apparatus having a simple structure,
An excellent effect that the service life of the electrode of such a processing apparatus can be made longer and the cost can be further reduced can be exhibited.
【0044】[0044]
【実施例】つぎに、本発明のコンタクトレンズの消毒洗
浄方法を実施例に基づいてさらに詳細に説明するが、本
発明はかかる実施例のみに限定されるものではない。EXAMPLES Next, the contact lens disinfecting and cleaning method of the present invention will be described in more detail based on examples, but the present invention is not limited to these examples.
【0045】実施例1〜7 硫酸ナトリウム1.1×10-1mol/リットル、ホウ
酸8.1×10-3mol/リットルおよびホウ砂2.4
×10-4mol/リットルを含有するpH6.8の溶液
に次亜塩素酸ナトリウムを添加し、次亜塩素酸の濃度が
20ppm、50ppmまたは100ppmとなるよう
に調整して処理液をえた。Examples 1 to 7 1.1 × 10 -1 mol / liter of sodium sulfate, 8.1 × 10 -3 mol / liter of boric acid and 2.4 of borax.
Sodium hypochlorite was added to a solution having a pH of 6.8 containing × 10 −4 mol / liter, and the concentration of hypochlorous acid was adjusted to 20 ppm, 50 ppm or 100 ppm to obtain a treatment liquid.
【0046】前記処理液3mlを電極面積が1.8cm
2 、電極間距離が1mmである一対の白金をセラミック
にメッキ処理した電極を有する処理容器に入れ、これに
含水率72重量%の薄い緑色に着色したソフトカラーコ
ンタクトレンズ(商品名ソフト72、(株)メニコン
製)を浸漬し、ついで表1に示す電圧および電流値で表
1に示す時間直流電流を流して消毒洗浄処理を施し、次
亜塩素酸を還元させた。このときの処理液中の次亜塩素
酸の濃度を表1に示す。なお、処理液中に残留した次亜
塩素酸の濃度は、(社)日本薬学会編『衛生試験法・注
解1990』金原出版(株)、P.949に記載の水質
試験法(オルトトリジンによる定量法)にしたがって測
定した。The electrode area of 1.8 ml of the treatment liquid (3 ml)
2. A pair of platinum with an inter-electrode distance of 1 mm is placed in a treatment container having a ceramic-plated electrode, and a soft green colored contact lens (product name software 72, ( (Manufactured by Menicon Co., Ltd.) was immersed, and then a direct current was applied at the voltage and current values shown in Table 1 for the time shown in Table 1 to perform a disinfecting and cleaning treatment to reduce hypochlorous acid. Table 1 shows the concentration of hypochlorous acid in the treatment liquid at this time. The concentration of the hypochlorous acid remaining in the treatment liquid was determined by "Physical Hygiene Test Method / Commentary 1990" edited by The Pharmaceutical Society of Japan, Kinbara Publishing Co., Ltd., P. It was measured according to the water quality test method described in 949 (quantitative method using orthotolidine).
【0047】比較例1〜2 実施例1と同様にして次亜塩素酸の濃度が50ppmま
たは100ppmとなるように調整し、処理液をえた。Comparative Examples 1 and 2 In the same manner as in Example 1, adjustment was made so that the concentration of hypochlorous acid was 50 ppm or 100 ppm, and a treatment liquid was obtained.
【0048】前記処理液3mlを実施例1と同様の処理
容器に入れてそのまま放置し、60分間経過後および1
20分間経過後に処理液中に残留した次亜塩素酸の濃度
を実施例1と同様にして測定した。その結果を表2に示
す。3 ml of the treatment liquid was placed in the same treatment container as in Example 1 and allowed to stand as it was, and after 60 minutes,
The concentration of hypochlorous acid remaining in the treatment liquid after 20 minutes was measured in the same manner as in Example 1. Table 2 shows the results.
【0049】[0049]
【表1】 [Table 1]
【0050】[0050]
【表2】 [Table 2]
【0051】表1および表2に示された結果から、実施
例1〜7においては、直流電流の通電開始後遅くとも2
時間以内には処理液中の次亜塩素酸は完全に還元されて
いるのに対し、直流電流を通電していない比較例1〜2
においては、2時間経過後も次亜塩素酸の濃度は当初の
半分程度にしか低下していないことがわかる。From the results shown in Table 1 and Table 2, in Examples 1 to 7, it was 2 at the latest after the start of direct current application.
The hypochlorous acid in the treatment liquid was completely reduced within the time, while Comparative Examples 1 and 2 in which no direct current was applied
In Fig. 2, it can be seen that the concentration of hypochlorous acid has dropped to only about half of the initial value even after 2 hours.
【0052】また、処理後のコンタクトレンズにおける
次亜塩素酸の有無を、該コンタクトレンズを0.1%オ
ルトトリジン塩酸溶液(和光純薬工業(株)製)を80
倍に希釈した溶液中に浸漬し、コンタクトレンズが黄色
に着色するかどうかによって調べた。その結果、0.1
ppm以上の次亜塩素酸が存在すれば、コンタクトレン
ズは黄色に着色するはずであるが、該コンタクトレンズ
はまったく変色せず、次亜塩素酸が還元されていること
がわかった。Further, the presence or absence of hypochlorous acid in the treated contact lens was checked by using a 0.1% orthotrizine hydrochloric acid solution (manufactured by Wako Pure Chemical Industries, Ltd.) for the contact lens.
The contact lens was immersed in a solution diluted two times, and it was examined whether the contact lens was colored yellow. As a result, 0.1
The presence of ppm or more of hypochlorous acid should cause the contact lens to be colored yellow, but the contact lens was not discolored at all and it was found that hypochlorous acid was reduced.
【0053】なお、コンタクトレンズの褪色もまったく
認められず、かかるコンタクトレンズをそのまま目に装
用しても何ら問題はなかった。No discoloration of the contact lens was observed at all, and there was no problem even if such a contact lens was worn on the eyes as it was.
【0054】つぎに、実施例1の処理液3mlを以下に
示す各微生物用に6種類用意し、各微生物を含む水0.
1mlをそれぞれの処理液に入れ、前記と同様の消毒処
理を行なった。実施例2〜7についても同様な処理を行
なった。Next, 6 types of 3 ml of the treatment liquid of Example 1 were prepared for each of the microorganisms shown below, and water containing each of the microorganisms of 0.
1 ml was put into each treatment solution and the same disinfection treatment as described above was performed. Similar processing was performed for Examples 2 to 7.
【0055】前記処理液について、各微生物(大腸菌
(Escherichia Coli、ATCC873
9)、緑膿菌(Pseudomonas aerugi
nosa、ATCC15442)、セラチア(Serr
atia marcescens、臨床分離菌、ATC
C13880)、黄色ブドウ球菌(Staphyloc
occus aureus、ATCC6538)、カン
ジタ(Candidaalbicans、ATCC10
231)、アスペルギルス(Aspergillus
fumigatus、ATCC10894)に対する消
毒(殺菌)効果試験を、平板希釈法によって処理液1m
lあたりの生菌数を測定して行なった。その結果を表3
に示す。なお、表3中、( )内には直流電流通電前
の各微生物の生菌の数(個/ml)を示した。[0055] For the treatment solution, each microorganism (E. coli (Escherichia Coli, ATCC873
9), Pseudomonas aerugi
nosa , ATCC15442), Serratia ( Serr
atia marcescens , clinical isolates, ATC
C13880), Staphylococcus aureus (Staphyloc
occus aureus , ATCC6538 ), Candida albicans , ATCC10
231), Aspergillus
Fumigatus , ATCC10894) disinfection (sterilization) effect test, 1m treatment liquid by plate dilution method
The measurement was performed by measuring the viable cell count per liter. Table 3 shows the results.
Shown in In Table 3, the numbers in parentheses () show the number of viable bacteria (cells / ml) of each microorganism before direct current application.
【0056】[0056]
【表3】 [Table 3]
【0057】表3に示された結果から、いずれの実施例
においても直流電流の通電終了までに生菌が完全に消滅
しているか、または通電前の生菌数と比べてきわめて少
量にまで減少しており、本発明の方法がすぐれた消毒
(殺菌)効果を奏するものであることがわかる。From the results shown in Table 3, in any of the examples, the viable bacteria were completely disappeared by the end of the energization with the direct current, or the viable cells were reduced to a very small amount compared with the number before the energization. Therefore, it can be seen that the method of the present invention has an excellent disinfection (sterilization) effect.
【0058】実施例8 実際のコンタクトレンズの装用を想定し、コンタクトレ
ンズに付着した微生物に対する消毒(殺菌)効果を調べ
た。Example 8 Assuming the actual wearing of contact lenses, the disinfection (sterilization) effect on the microorganisms adhering to the contact lenses was examined.
【0059】含水率38重量%の薄い青色に着色したソ
フトカラーコンタクトレンズ(商品名ソフトMA、
(株)メニコン製)20枚(レンズ番号:1〜20)
に、実施例1〜7で用いたものと同じアスペルギルス
を、1枚につき1.3×106 個付着させた。Soft-colored contact lenses colored under light blue with a water content of 38% by weight (trade name Soft MA,
20 pieces (lens number: 1-20) manufactured by Menicon Co., Ltd.
Then, 1.3 × 10 6 pieces of the same Aspergillus as those used in Examples 1 to 7 were attached to each sheet.
【0060】つぎに、次亜塩素酸が含有されていないほ
かは実施例3で用いられたものと同じ処理液を調製し、
かかる処理液で、前記レンズ番号1〜20の各コンタク
トレンズをそれぞれ20秒間手指にて洗浄し、ついで2
0秒間手のひら洗浄をし、再び20秒間手指にて洗浄し
た。Next, the same treatment liquid as that used in Example 3 was prepared except that hypochlorous acid was not contained,
Each of the contact lenses having the lens numbers 1 to 20 was washed with the treatment liquid for 20 seconds by hand, and then 2
The palm was washed for 0 seconds and again for 20 seconds with fingers.
【0061】つぎに、実施例3で用いられた含水率72
重量%の薄い緑色に着色したソフトカラーコンタクトレ
ンズのかわりに前記のごとく洗浄した各コンタクトレン
ズを用いたほかは、実施例3と同様にしてコンタクトレ
ンズを浸漬し、ついで直流電流を10分間通電させて消
毒処理を施し、次亜塩素酸を還元させた。Next, the water content used in Example 3 was 72.
The contact lens was immersed in the same manner as in Example 3 except that each of the contact lenses washed as described above was used instead of the soft color contact lens colored in a light weight of 10% by weight, and then a direct current was applied for 10 minutes. Was disinfected to reduce hypochlorous acid.
【0062】通電終了後の処理液およびコンタクトレン
ズに残存する生菌(アスペルギルス)の数を平板希釈法
によって測定した。その結果を表4に示す。The number of viable bacteria (Aspergillus) remaining on the treatment liquid and the contact lens after completion of energization was measured by the plate dilution method. Table 4 shows the results.
【0063】[0063]
【表4】 [Table 4]
【0064】表4に示された結果から、いずれのコンタ
クトレンズにおいても生菌が完全に消滅しており、また
ほとんどすべての処理液において生菌が完全に消滅して
いることから、本発明の方法が、実際のコンタクトレン
ズの装用を考慮してきわめてすぐれた消毒(殺菌)効果
を奏するものであることがわかる。From the results shown in Table 4, the viable cells were completely eliminated in all contact lenses, and the viable cells were completely eliminated in almost all the treatment solutions. It can be seen that the method has an extremely excellent disinfection (sterilization) effect in consideration of actual wearing of contact lenses.
【0065】実施例9〜15 N−ビニルピロリドンを主成分とする含水率70重量%
のソフトコンタクトレンズ17枚を用意し、これらのう
ち16枚を以下の組成の人工涙液(pH7)1.5ml
中に37℃で1時間浸漬した。Examples 9 to 15 Water content of N-vinylpyrrolidone as main component 70% by weight
17 soft contact lenses are prepared, and 16 of them are 1.5 ml of artificial tears (pH 7) having the following composition.
It was immersed in this at 37 ° C. for 1 hour.
【0066】(人工涙液の組成) アルブミン 11.64g γ−グロブリン 4.83g リゾチーム 3.6g NaCl 9.0g CaCl2 ・2H2 O 0.15g NaH2 PO4 ・2H2 O 1.04g 蒸留水 1.0リットル つぎに、前記人工涙液に浸漬したコンタクトレンズのう
ち、14枚をメニクリーン(商品名、(株)メニコン
製)を用いて手指にて洗浄したのち、実施例1〜7で用
いたものと同じ処理液および処理容器を用い、これに各
2枚のコンタクトレンズを浸漬し、ついで処理液中の次
亜塩素酸の濃度が0.1ppm以下になるまで直流電流
を通電させて洗浄処理を施した。これら人工涙液に浸漬
する操作と洗浄処理を施す操作とをあわせてサイクルテ
ストAという。(Composition of artificial tears) Albumin 11.64 g γ-globulin 4.83 g Lysozyme 3.6 g NaCl 9.0 g CaCl 2 .2H 2 O 0.15 g NaH 2 PO 4 .2H 2 O 1.04 g distilled water 1.0 liter Next, among the contact lenses immersed in the artificial tears, 14 pieces were washed with fingers using Meniclean (trade name, manufactured by Menicon Co., Ltd.), and then in Examples 1 to 7. Using the same treatment liquid and treatment container as used, dip each two contact lenses in it, and then apply a direct current until the concentration of hypochlorous acid in the treatment liquid becomes 0.1 ppm or less. It was washed. The operation of immersing in these artificial tears and the operation of performing the washing treatment are collectively referred to as cycle test A.
【0067】前記サイクルテストAを100サイクル行
なったのち、コンタクトレンズを目視にて観察し、その
透明性を以下の評価基準に基づいて評価した。その結果
を、直流電流通電前の次亜塩素酸の濃度とあわせて表5
に示す。After 100 cycles of the cycle test A, the contact lens was visually observed and its transparency was evaluated based on the following evaluation criteria. The results are shown in Table 5 together with the concentration of hypochlorous acid before direct current application.
Shown in
【0068】(評価基準) A:サイクルテストAを行なっていないコンタクトレン
ズとまったく同様のすぐれた透明性を有する。(Evaluation Criteria) A: The lens has the same excellent transparency as a contact lens not subjected to the cycle test A.
【0069】B:サイクルテストAを行なっていないコ
ンタクトレンズと比べて少し白濁が認められる。B: A little cloudiness is recognized as compared with the contact lens which was not subjected to the cycle test A.
【0070】C:白濁がいちじるしい。C: White turbidity is remarkable.
【0071】[0071]
【表5】 [Table 5]
【0072】表5に示された結果から、サイクルテスト
Aを100サイクル行なったのちのコンタクトレンズは
透明性にすぐれ、本発明の方法によって蛋白質の除去が
充分に行なわれていることがわかる。なお、かかるサイ
クルテストAを100サイクル行なったのちでも、コン
タクトレンズの損傷などはまったく認められなかった。From the results shown in Table 5, it can be seen that the contact lens after 100 cycles of the cycle test A has excellent transparency and that the protein of the present invention is sufficiently removed by the method of the present invention. Even after 100 cycles of the cycle test A, the contact lens was not damaged at all.
【0073】比較例3 実施例9〜15で人工涙液に浸漬した16枚のコンタク
トレンズのうちの残りの2枚について、メニクリーンを
用いて手指にて洗浄したのち、メニソーク(商品名、
(株)メニコン製)1.5ml中に浸漬して煮沸消毒器
(商品名、ライザーE、(株)メニコン製)を用いてコ
ンタクトレンズに煮沸消毒処理を施した。これら人工涙
液に浸漬する操作と煮沸消毒処理を施す操作とをあわせ
てサイクルテストBという。Comparative Example 3 The remaining two lenses out of the 16 contact lenses immersed in the artificial tears in Examples 9 to 15 were washed with Meniclean with fingers and then Menisork (trade name,
The contact lens was immersed in 1.5 ml of Menicon Co., Ltd. and boiled and disinfected using a boiling disinfection device (trade name, Riser E, manufactured by Menicon Co., Ltd.). The operation of immersing in these artificial tears and the operation of performing boiling disinfection treatment are collectively referred to as cycle test B.
【0074】前記サイクルテストBを100サイクル行
なったが、ライザーEを用いて煮沸消毒処理を施した2
枚のコンタクトレンズは、サイクルテストBを30サイ
クル程度行なったころから白濁していることが肉眼でわ
かるようになった。さらに100サイクル終了後、コン
タクトレンズの白濁の原因を追求するためにX線マイク
ロアナライザーにより硫黄(蛋白質由来)およびリン
(リン酸カルシウム由来)の存在の有無を調べたとこ
ろ、硫黄の存在を示すピークが検出された。100 cycles of the cycle test B were carried out, and boiled and disinfected using the riser E 2
It became apparent to the naked eye that the contact lenses became cloudy after about 30 cycles of cycle test B. After 100 cycles, the presence or absence of sulfur (from protein) and phosphorus (from calcium phosphate) was examined with an X-ray microanalyzer to investigate the cause of cloudiness of the contact lens, and a peak indicating the presence of sulfur was detected. Was done.
【0075】したがって、このコンタクトレンズの白濁
はタンパク質によるものと推定され、本発明の方法によ
る処理を行なわないばあいには、コンタクトレンズ内に
蛋白質が蓄積されることがわかる。なお、リンの存在を
示すピークは検出されなかった。Therefore, it is presumed that the cloudiness of the contact lens is caused by the protein, and that the protein is accumulated in the contact lens when the treatment by the method of the present invention is not carried out. A peak indicating the presence of phosphorus was not detected.
【0076】実施例16および比較例4 実施例9〜15と同様にして2枚のコンタクトレンズを
人工涙液1.5ml中に37℃で1時間浸漬し、メニク
リーンを用いて手指にて洗浄したのち、次亜塩素酸が含
有されていないほかは実施例3で用いられたものと同じ
処理液に浸漬し、ライザーEにて消毒処理を施した。つ
ぎに前記コンタクトレンズ2枚を室温まで放冷した。Example 16 and Comparative Example 4 In the same manner as in Examples 9 to 15, two contact lenses were immersed in 1.5 ml of artificial tear fluid at 37 ° C. for 1 hour and washed with fingers using Meniclean. After that, it was immersed in the same treatment liquid as that used in Example 3 except that it did not contain hypochlorous acid, and was subjected to disinfection treatment with a riser E. Next, the two contact lenses were allowed to cool to room temperature.
【0077】前記操作を1サイクルとし、かかる操作5
0サイクル行なったのち、コンタクトレンズを目視にて
観察したところ、2枚とも30サイクル程度行なったこ
ろから白濁していることがわかるようになった。The above operation is defined as one cycle, and the operation 5
After 0 cycles, the contact lenses were visually observed, and it became apparent that the two lenses became cloudy after about 30 cycles.
【0078】このことから、前記次亜塩素酸が含有され
ていない処理液を用いたライザーEによる煮沸処理で
は、蛋白質をコンタクトレンズから充分に除去すること
ができないことがわかる(比較例4)。From this, it is understood that the protein cannot be sufficiently removed from the contact lens by the boiling treatment with the riser E using the treatment solution containing no hypochlorous acid (Comparative Example 4).
【0079】さらに、実施例3と同様の処理液および処
理容器を用い、50サイクル行なったのちの白濁したコ
ンタクトレンズのうち1枚を該処理液に浸漬し、ついで
10V、160mAで10分間直流電流を通電して消毒
洗浄処理を施した。そののちコンタクトレンズを処理容
器から取り出し、目視にて観察したところ、透明なコン
タクトレンズに戻っていた(実施例16)。Further, using the same treatment liquid and treatment container as in Example 3, one of the cloudy contact lenses after 50 cycles was immersed in the treatment liquid and then a direct current of 10 V and 160 mA for 10 minutes. Was energized for disinfection and cleaning treatment. After that, the contact lens was taken out from the processing container and visually observed, and it was returned to a transparent contact lens (Example 16).
【0080】このことから、蛋白質が熱変性によって固
着したコンタクトレンズにおいても、本発明の方法によ
って蛋白質を除去することが可能であることがわかる。From this, it is understood that the protein can be removed by the method of the present invention even in a contact lens in which the protein is fixed by heat denaturation.
【0081】[0081]
【発明の効果】本発明のコンタクトレンズの消毒洗浄方
法によれば、次亜ハロゲン酸のすぐれた消毒力および洗
浄力によってコンタクトレンズを消毒洗浄させるととも
に、かかる次亜ハロゲン酸をすみやかに無毒化させるこ
とができるという効果が奏される。According to the disinfecting and cleaning method for contact lenses of the present invention, the contact lens is disinfected and cleaned by the excellent disinfecting power and cleaning power of hypohalous acid, and the hypohalous acid is quickly detoxified. The effect of being able to do is exhibited.
【0082】また、本発明の消毒洗浄方法は、処理液に
直流電流を通電するだけでよいので、構造が簡単なコン
タクトレンズ処理装置に好適に使用することができ、か
かる処理装置の電極の耐用日数をより長くし、さらに低
コスト化を図ることができるといったすぐれた効果を奏
する。Further, since the disinfecting and cleaning method of the present invention only needs to pass a direct current to the treatment liquid, it can be suitably used for a contact lens treatment device having a simple structure, and the durability of the electrodes of such treatment device can be improved. It has an excellent effect that the number of days can be extended and the cost can be further reduced.
Claims (3)
ゲン酸を含有する処理液中にコンタクトレンズを浸漬し
たのち、前記処理液に直流電流を通電することを特徴と
するコンタクトレンズの消毒洗浄方法。1. A method for disinfecting and cleaning a contact lens, which comprises immersing a contact lens in a treatment solution containing no halogenide but containing hypohalous acid, and then applying a direct current to the treatment solution. .
1〜200ppmである請求項1記載のコンタクトレン
ズの消毒洗浄方法。2. The concentration of hypohalous acid in the treatment liquid is 0.
The method for disinfecting and cleaning a contact lens according to claim 1, which is 1 to 200 ppm.
0.001〜0.5Aである請求項1または2記載のコ
ンタクトレンズの消毒洗浄方法。3. The disinfecting and cleaning method for a contact lens according to claim 1, wherein the current value of the direct current supplied to the treatment liquid is 0.001 to 0.5 A.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7315398A JPH09154922A (en) | 1995-12-04 | 1995-12-04 | Sterilization washing method for contact lens |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7315398A JPH09154922A (en) | 1995-12-04 | 1995-12-04 | Sterilization washing method for contact lens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH09154922A true JPH09154922A (en) | 1997-06-17 |
Family
ID=18064919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7315398A Pending JPH09154922A (en) | 1995-12-04 | 1995-12-04 | Sterilization washing method for contact lens |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH09154922A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001041572A1 (en) * | 1999-12-10 | 2001-06-14 | Kao Corporation | Methods of sterilization |
| WO2001041571A1 (en) * | 1999-12-10 | 2001-06-14 | Kao Corporation | Microbicide compositions |
| JP2017510354A (en) * | 2014-04-03 | 2017-04-13 | ノバルティス アーゲー | Electrochemical system for disinfecting and cleaning contact lenses |
| CN113848192A (en) * | 2020-07-31 | 2021-12-28 | 苏州三个臭皮匠生物科技有限公司 | Method for effectively detecting concentration of protein in solution containing available chlorine |
| CN115337421A (en) * | 2021-05-12 | 2022-11-15 | 林锦鸿 | Disinfection and sterilization method |
-
1995
- 1995-12-04 JP JP7315398A patent/JPH09154922A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001041572A1 (en) * | 1999-12-10 | 2001-06-14 | Kao Corporation | Methods of sterilization |
| WO2001041571A1 (en) * | 1999-12-10 | 2001-06-14 | Kao Corporation | Microbicide compositions |
| US6793846B2 (en) | 1999-12-10 | 2004-09-21 | Kao Corporation | Microbicide compositions |
| JP2017510354A (en) * | 2014-04-03 | 2017-04-13 | ノバルティス アーゲー | Electrochemical system for disinfecting and cleaning contact lenses |
| US10525158B2 (en) | 2014-04-03 | 2020-01-07 | Novartis Ag | Electrochemical system for disinfecting and cleaning contact lenses |
| CN113848192A (en) * | 2020-07-31 | 2021-12-28 | 苏州三个臭皮匠生物科技有限公司 | Method for effectively detecting concentration of protein in solution containing available chlorine |
| CN115337421A (en) * | 2021-05-12 | 2022-11-15 | 林锦鸿 | Disinfection and sterilization method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR960006144B1 (en) | Method for simultaneously cleaning and disinfecting contact lenses and compositions thereof | |
| US4997626A (en) | Methods to disinfect contact lenses | |
| JPH07168145A (en) | Preparation for cleaning and disinfecting contact lenses | |
| EP0509021A1 (en) | Methods and compositions to disinfect lenses | |
| US20040234569A1 (en) | Disinfection method | |
| US5449442A (en) | Cleaning and disinfecting method for contact lens | |
| US5820696A (en) | Method of cleaning and disinfecting contact lens | |
| NZ241658A (en) | Contact lenses cleaning composition containing enzyme and chlorine dioxide destroying component | |
| US5487788A (en) | Method for cleaning and disinfecting contact lens | |
| JPH09154922A (en) | Sterilization washing method for contact lens | |
| US5447650A (en) | Composition for preventing the accumulation of inorganic deposits on contact lenses | |
| JP2669690B2 (en) | Contact lens cleaning method and cleaning sterilization method | |
| JP2840301B2 (en) | Method for removing protein stain adhering to colored contact lens and cleaning agent therefor | |
| WO1998020912A1 (en) | Treatment composition for contact lenses and method for treating contact lenses with the same | |
| JP3552838B2 (en) | Contact lens solution and cleaning and disinfecting method using the same | |
| JPH07181436A (en) | Cleaning and aterilizing method of contact lens | |
| JP2002122827A (en) | How to clean and disinfect contact lenses | |
| JPH0614978A (en) | Washing/sterilizing method | |
| JP2007140219A (en) | Agent for contact lens | |
| EP0563911A1 (en) | Cleaning and disinfecting method | |
| JPH04242649A (en) | Method of disinfecting moisture content type color contact lens | |
| JP3022989B2 (en) | Method for cleaning and disinfecting soft contact lenses and treatment solution for soft contact lenses | |
| JPH08122717A (en) | Electrolytic ion water disinfection device and disinfection neutralization method | |
| JPH10137327A (en) | Antifouling composition for contact lens and antifouling method of contact lens using the composition | |
| JP2003167220A (en) | Composition for contact lens and method of cleaning and sterilizing contact lens using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050127 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050531 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20051004 |